Supportive medical care remains the foundation of Ebola treatment.

Ebola virus disease can cause fever, vomiting, diarrhea, bleeding, dehydration, and kidney and liver failure. Patients often become severely ill because they lose large amounts of fluids and their organs may begin to fail. 

Doctors treat Ebola patients with supportive care such as: 

• Oral or intravenous fluids 

• Oxygen support 

• Blood pressure management 

• Treatment for secondary infections 

• Pain and fever control 

Research during past Ebola outbreaks showed that high-quality supportive care can significantly improve survival, especially when patients receive care early and have access to well-equipped medical facilities. 

Some Ebola treatments have been proven effective through clinical trials.

During the 2014–2016 Ebola outbreak in West Africa, researchers and public health officials worked to test experimental treatments during the emergency response. Clinical trials later identified antibody-based therapies that improved survival for patients infected with Zaire ebolavirus, the species responsible for several major Ebola outbreaks. 

In 2020, the U.S. Food and Drug Administration approved two treatments for Zaire ebolavirus infection: 

• Inmazeb 

• Ebanga 

These medicines use laboratory-made antibodies that help the immune system target the virus. 

Research conducted during Ebola outbreaks helped scientists determine which treatments worked and which did not. Experts have emphasized that careful clinical research during epidemics is essential for identifying safe and effective therapies. 

Existing Ebola treatments may not work for every Ebola virus.

“Ebola virus” actually refers to several related viruses. The two FDA-approved Ebola treatments were developed and approved for infections caused by Zaire ebolavirus and should not be assumed to be effective against other species of the virus. 

The current outbreak in Uganda and the Democratic Republic of the Congo involves Bundibugyo virus, a different species of Ebola virus. Scientists are still studying whether existing treatments will work well against it. 

This can create confusion because news reports may refer broadly to “Ebola treatments” or “Ebola vaccines,” even though some products were designed for specific Ebola viruses. 

Unproven remedies can delay lifesaving care.

Past Ebola outbreaks generated false claims about cures involving saltwater, high-dose vitamins, herbal remedies, colloidal silver, and other untested products. Public health experts warned that these claims could cause people to delay medical treatment or avoid trusted healthcare providers. 

Researchers determine whether treatments work by conducting clinical trials that are designed to show whether those treatments are safe and effective. Anecdotes, social media posts, and individual testimonials cannot prove whether a treatment is safe or effective. 

Health officials continue to monitor potential new treatments during outbreaks, but therapies should be evaluated through rigorous scientific testing before they are widely used.  

Early treatment and trusted information are critical.

People who may have been exposed to Ebola should follow guidance from public health authorities and seek medical care promptly. Early diagnosis, supportive medical care, and evidence-based treatments can improve survival.